Becton Dickinson raises lower end of annual profit forecast on drug delivery devices strength

The company expects fiscal 2027 revenue growth ​to start from a low-single-digit baseline, taking a conservative posture due to volatility in oil prices, CEO Tom Polen said ​on a post earnings call.

Leave a Reply